results: We present two cases of PD with motor complications due to long term L-dopa treatment that developed their first episodes of mania with psychotic symptoms after bilateral STN-DBS implantation. DBS-induced psychiatric adverse effects may be attributable either to limbic connections and STN-specific oscillations or stimulation of the medial forebrain bundle.
Manic Episode Following Deep Brain Stimulation of the Subthalamic Nucleus for parkinson's Disease: A Case Report

Parkinson Hastalığında Subtalamik Nükleusun Derin Beyin Stimülasyonu Sonrası Gelişen Manik Atak: Bir Olgu Sunumu
InTRoduCTIon
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, resting tremor, rigidity and postural instability. Psychiatric symptoms can ocur in 61% of the patients either due to disease itself or medication adverse effects. In 30-40% of patients have depression and 30% have psychosis related to seratonergic and dopaminergic deficits in the mesolimbic and mesocortical Networks (20) .
Over the last two decades surgical therapies became the second most important therapeutic application after L-dopa and dopamine agonists. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is one of the major targets for relieving severe tremor or motor complications of long term L-dopa therapy. High frequency stimulation of STN in severely disabled patients due to motor complications of dopaminergic treatment is associated with a marked improvement in the quality of life measures (6, 1). However, it has been reported that a wide spectrum of behavioral change and psychiatric adverse effects occur as high as 41% for cognitive deficits, 8 % for depression, 4% for acute hypomania (16, 17) .
Here we report two cases of patients who developed manic episodes in the early postoperative period following bilateral STN-DBS.
CASe 1
A 56-year-old woman with a 12 year history of PD had been treated with L-dopa. Although relieving her bilateral resting tremor, bradykinesia, the best management of her treatment did not succeed in decreasing the motor complications of the Quadripolar electrodes (Medtronic 37601 activa PC) were implanted bilaterally with stereotactic methods as described elsewhere (7) . On postoperative day 7 (5th day of escitalopram treatment) she developed inappropriate behaviors such as running in the hall, singing out loud and undressing. Her postoperative psychiatric evaluation revealed increased and rapid speech, racing thoughts, disjointed thinking, euphoria, grandiosity, persecutive hallucinations, religious activities, increased libido, psychomotor activity, insomnia, deterioration of reality assessment and judgment and lack of insight. Young Mania Scoring Scale (YMSS) was 38 and diagnosed as manic episode with psychotic symptoms, eventually put on 10mg/d olanzapine and escitalopram was ceased. In follow-up psychiatric evaluation after one month she had none of the previous manic symptoms and YMSS was 0. Olanzapine was tapered down and ceased. In her neurological examination UPDRS score was 10 "on stimulation" and "on medication" and severe dyskinesias disappeared. After her second follow-up visit she was put on 10mg/d escitalopram because of anxiety, decreased libido and increased appetite. Ten months after STN-DBS implantation she was euthymic and had no manic symptoms.
CASe 2
A 57-year-old man with a 10-year history of unilateral tremor and bradykinesia was admitted to neurosurgery clinic for STN-DBS implantation because of severe motor complications of L-dopa treatment. His neurological examination revealed bilateral resting tremor and bradykinesia predominating on the left side of his body. Motor score of UPDRS was 30 "off" medication. In his preoperative psychiatric evaluation there was no active psychopathology. Bilateral STN-DBS implantation was carried out as described above. In the third postoperative day he was re-evaluated because of elevated mood, increased speech, hyperactivity and spending sprees. His psychiatric evaluation revealed increased and rapid speech, racing thoughts, disjointed thinking and euphoria. YMSS was 26 and was put on 1mg/d haloperidol, tapered to 2mg/d. During the following weeks his manic symptoms subsided and YMSS was 0. Motor scores of UPDRS reduced to 7 "on stimulation" and "on medication" and peak-dose dyskinesias disappeared. During his follow-up visit for increased tremor and bradykinesia stimulation intensity was increased. Approximately 24 hours following the new parameter settings (bipolar 3.5 V 90μsec, 180 Hz) he developed an abrupt manic reaction which gradually subsided in 3 days after switching to more dorsal electrode contacts.
dISCuSSIon
We present two cases of PD with motor complications due to long term L-dopa treatment that developed their first episodes of mania with psychotic symptoms after bilateral STN-DBS implantation. Several authors have reported a wide spectrum of psychiatric alterations after STN-DBS, such as depression, manic episode and anxiety (19, 18, 13, 8, 2, 15, 21) . A decompensation of preexisting psychiatric disorders such as depression and anxiety disorders can be induced by STN-DBS. Krack and colleagues reported a case with mirthful laughter when stimulated with supramaximal parameters (9) . Besides, hypomania/mania has also been reported by many authors (19, 18, 13, 8 ). Romito and associates described 2 patients with transient mania associated with hypersexuality appeared in several days after initiation of STN stimulation. In these cases stimulation arrest did not acutely influence manic symptoms (14) . Our first case STN-DBS related mania appeared on postoperative day 7 and continued for 1 month and gradually subsided with medical treatment. We think that her underlying affective disorder may be a predisposing factor for her DBS induced mania. In another report a reversible manic behavior was related to stimulation of contacts misplaced to caudal STN in the midbrain level and the manic behavior disappeared after stimulation of a different contact located in the level of STN. Thus, the authors concluded that manic disorders might be caused by affection of structures in the ventral midbrain (10) . Similarly, Raucher-Chene and colleagues (13) reported a patient with manic episodes due to STN-DBS who responded to the change in stimulation target. They suggested that medial part of the STN play a key role in the occurrence of manic symptoms. However, Herzog and associates (8) suggested that stimulation of the STN, but not the adjacent structures resulted in manic psychosis. In their report bilateral monopolar stimulation of STN resulted in hypomanic state which progressed to a manic episode with psychotic symptoms in 3 weeks. Stimulation arrest was intolerable because of immediate worsening of motor symptoms. The patient has been put on 150mg/d clozapine which alleviated the psychotic symptoms. However, mixed features both with mania and depression at the same time led to the diagnosis of organic bipolar disorder which is attributed to stimulation of STN but not adjacent structures. There is a similarity between hypomania in bipolar disorder and DBS-induced hypomania. In DBS-induced hypomania patients often report that they feel possessed (8, 14) . They are overactive without signs of exhaustion. They engage in individually specific but overlapping risk-taking activities such as hypersexuality, gambling and money spending. Many authors had suggestions on the anatomic and functional correlates of these symptoms with STN stimulation. In our second case, manic symptoms appeared on postoperative day 3 and continued for a few weeks. He also reported hyperactivity and spending like in cases previously reported (8, 14) . We think that, the stimulation of caudal STN has an important influence on the appearance of manic symptoms, because an abrupt manic reaction occurred which gradually subsided in 3 days after switching to more dorsal electrode contacts.
The STN has an anatomically central position within the basal ganglia-thalamocortical associative and limbic circuits. Despite the fact that it is a very small structure, it is a major player in the input and output of the basal ganglia motor circuitry. The involvement of the STN in motor function regulation is obvious and its stimulation has an immediate and robust clinical effect on PD. This may be explained by its role within the basal gangliathalamocortical circuitry. Besides its control on motor activity, the STN is involved in the processing of certain cognitive and executive functions and modulating motivation (3, 4) . These features may be related to dopamine dysregulation syndrome, impulse control disorders and punding in PD (11) . However, the involvement of STN in non-motor function is less robust and usually temporary. Therefore STN may be an indirect modulator of non-motor functions. Most authors postulate that STN induced psychiatric adverse effects are a result of diffusion of current into the inferior and medial STN, influencing its limbic subnucleus and its associated circuitry (17, 10) . Recent functional neurosurgery has provided the opportunity to record directly from the human basal ganglia, most commonly in patients with PD undergoing DBS electrode implantation. The studies focusing on single unit recordings and local field potentials recorded intraoperatively via microelectrodes demonstrated that specific oscillations in the STN are involved in decisional processes, cognitive functions, emotion control and conflict that could explain the post-DBS occurrence of behavioral disturbances (12) . However in a single report acute hypomania induced during STN-DBS attributed to activation of medial forebrain bundle which is a structure of the reward circuitry and a key structure of mesolimbic-dopamine system that is related to affective disorders, drug addiction and learning (5).
In conclusion, DBS-induced psychiatric adverse effects may be attributable either to limbic connections and STN-specific oscillations or stimulation of the medial forebrain bundle. The exact role of the STN and the basal ganglia in non-motor functions remains an important and interesting challenge for future research.
